Copper
For informational purposes only — not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen. Full disclaimer →
- Copper is essential for iron transport — copper deficiency impairs iron metabolism and can cause iron-deficiency-like anemia despite normal iron intake. Ceruloplasmin requires copper to function as a ferroxidase — the enzyme that oxidizes ferrous iron (Fe²⁺) to ferric iron (Fe³⁺) for loading onto transferrin. Without adequate copper, iron cannot be mobilized from storage (liver, intestinal cells) into the bloodstream efficiently. This produces an anemia that resembles iron deficiency on blood counts (low hemoglobin, hypochromic cells) but that does not respond to iron supplementation — a diagnostic pitfall when copper is not measured. The same mechanism explains why very high doses of zinc supplements cause copper-deficiency anemia: zinc competes with copper for absorption, and prolonged high-dose zinc use is a common cause of copper deficiency.
- Copper:zinc ratio is an independent predictor of cardiovascular and all-cause mortality — more informative than either mineral alone. Large prospective studies including analyses from NHANES have found that higher copper:zinc ratios (above 1.5–2.0) are associated with significantly elevated cardiovascular mortality, independent of traditional risk factors. This ratio captures systemic inflammatory and redox status: copper rises with inflammation (it is an acute-phase reactant); zinc falls with inflammation; their ratio amplifies both signals simultaneously. Optimizing the copper:zinc ratio by ensuring adequate zinc alongside appropriate copper intake is a practical target.
- Excess zinc supplementation is the most common cause of copper deficiency in adults in high-income countries. Zinc and copper compete for intestinal absorption through shared metallothionein transporters. High-dose zinc supplementation (above 40–50 mg/day for extended periods) reliably induces copper deficiency by competitively blocking copper absorption. This occurs with common zinc supplementation practices in longevity and immunology communities. Anyone supplementing above 25 mg/day of zinc daily should consider concurrent low-dose copper supplementation (1–2 mg/day) and periodic copper:zinc testing.
- Copper is required for superoxide dismutase (SOD1), the primary cytoplasmic antioxidant enzyme — making it central to oxidative stress defense. Cu/Zn-SOD1 dismutates the superoxide radical (O₂⁻) into hydrogen peroxide and oxygen — the first step in the two-enzyme antioxidant cascade (SOD1 → catalase/glutathione peroxidase). SOD1 activity falls with copper deficiency, reducing the cell's capacity to handle superoxide produced by normal mitochondrial respiration and by phagocytic immune cells. This may explain part of the immune dysfunction associated with copper deficiency.
- Copper is essential for lysyl oxidase — the enzyme that cross-links collagen and elastin in arterial walls and connective tissue. Lysyl oxidase requires copper to catalyze the oxidative deamination of lysyl residues in collagen and elastin, forming cross-links that give connective tissue mechanical strength. Copper deficiency impairs arterial wall integrity, contributing to the aortic aneurysms and cardiovascular pathology seen in severe deficiency. This mechanism is also relevant to skin aging — copper-dependent lysyl oxidase activity supports the collagen matrix that maintains skin elasticity.
The Copper:Zinc Ratio — A Practical Longevity Marker
Individual serum copper and zinc values are moderately useful in isolation. Their ratio is more informative because it captures the inverse relationship between these minerals under inflammatory conditions — copper rises as an acute-phase reactant while zinc falls — amplifying the signal from both directions simultaneously.
The epidemiological evidence linking elevated copper:zinc ratios to mortality outcomes is striking. Analysis of NHANES III data found that individuals in the highest quartile of the copper:zinc ratio had significantly higher all-cause and cardiovascular mortality compared to those in the lowest quartile, with effect sizes comparable to established cardiovascular risk factors. Similar findings have emerged from the EPIC-Norfolk cohort and other large prospective studies.
The mechanistic plausibility is strong: high copper:zinc ratios reflect simultaneous copper excess (pro-oxidant, pro-inflammatory through copper-catalyzed ROS generation) and zinc deficiency (impaired antioxidant defense via Cu/Zn-SOD1, impaired immune function, impaired insulin signaling). This combination produces a metabolically hostile state that correlates with adverse outcomes across disease categories. 1
Zinc Supplementation and Copper Depletion: A Common Overlooked Interaction
Zinc and copper compete for intestinal absorption at the level of metallothionein proteins in intestinal enterocytes. When zinc intake is high, metallothionein expression increases, sequestering both zinc and copper within enterocytes. Zinc is released into the portal blood, but copper is trapped and eventually lost when intestinal cells are shed. The net result is reduced copper absorption.
This interaction is dose-dependent and clinically significant at supplemental zinc doses above 40–50 mg/day. The clinical presentation of zinc-induced copper deficiency is insidious: neutropenia may develop over months, followed by anemia and, in severe cases, neurological symptoms from copper deficiency myelopathy. Because practitioners rarely connect zinc supplementation to neurological decline, this diagnosis is frequently delayed.
The practical solution: anyone supplementing zinc above 25 mg/day should co-supplement with 1–2 mg/day of copper and monitor the copper:zinc ratio annually.
| Serum Copper | Cu:Zn Ratio | Status |
|---|---|---|
| < 70 µg/dL | < 0.8 | Low — assess for zinc excess or malabsorption |
| 80–120 µg/dL | < 1.2 | Longevity optimal |
| 120–140 µg/dL | 1.2–1.5 | High-normal — assess inflammatory context |
| > 140 µg/dL | > 1.5 | Elevated — rule out inflammation; assess for excess |
| Range Type | Value (µg/dL) | Notes |
|---|---|---|
| Standard Clinical Range | 70–140 µg/dL (serum copper) | Designed to identify disease risk — not longevity optimisation. |
| Longevity-Optimal Target | 80–120 µg/dL · Copper:Zinc ratio < 1.2 |
Associated with reduced all-cause mortality and extended healthspan.
Serum copper is an acute-phase reactant — it rises with inflammation, making it an unreliable measure of copper status during illness, infection, or significant inflammatory states. Ceruloplasmin measurement alongside serum copper provides additional context. The copper:zinc ratio (both in µg/dL) is more informative than either alone and should be < 1.2 ideally; ratios above 1.5–2.0 are consistently associated with elevated cardiovascular and all-cause mortality in large cohort studies. Women have naturally higher serum copper (often 10–25% higher) due to estrogen's stimulatory effect on ceruloplasmin synthesis — sex-specific interpretation is important.
|
Already have your results? See what your Copper and other markers reveal about your longevity in 60 seconds.
Analyze My Labs →Affiliate disclosure: we may earn a commission if you purchase through these links at no extra cost to you.
What is the copper:zinc ratio and how do I calculate it?
The copper:zinc ratio is simply serum copper (in µg/dL) divided by serum zinc (in µg/dL). For example, serum copper of 90 µg/dL and serum zinc of 80 µg/dL gives a ratio of 1.13 — within the optimal range. Serum copper of 130 µg/dL and serum zinc of 60 µg/dL gives a ratio of 2.17 — meaningfully elevated, associated with increased inflammatory and cardiovascular risk in population data. Both Ulta Lab Tests offers both copper and zinc individually; order them together and calculate the ratio from your results. The ratio is most informative when drawn in a stable, non-acutely-ill state, since both copper and zinc fluctuate substantially with acute illness.
What are the symptoms of copper deficiency?
Mild copper deficiency is often asymptomatic or produces nonspecific fatigue and impaired immune function. More significant deficiency produces: anemia (often macrocytic from impaired iron mobilization, or normocytic — typically not responsive to iron supplementation); neutropenia (low neutrophil count, impaired immune defense); and neurological symptoms from copper deficiency myelopathy — subacute combined degeneration of the spinal cord with gait instability, sensory loss, weakness, and balance problems that can be irreversible. Copper deficiency myelopathy is clinically indistinguishable from B12 deficiency myelopathy and is diagnosed when B12 is normal but serum copper and ceruloplasmin are low. This diagnosis is particularly important to consider in patients with gastric bypass surgery, celiac disease, or excessive zinc supplementation.
What is Wilson's disease and when does it cause elevated copper?
Wilson's disease is an autosomal recessive genetic disorder caused by mutations in ATP7B — a copper-transporting ATPase. Normally, ATP7B exports excess copper from hepatocytes into bile for excretion. In Wilson's disease, this export is defective, and copper accumulates progressively in the liver (causing hepatitis, cirrhosis), the brain (causing neurological and psychiatric symptoms), the cornea (Kayser-Fleischer rings), and other organs. Paradoxically, serum copper in Wilson's disease can be low or normal (most copper is not being exported into plasma-bound ceruloplasmin), while liver copper is massively elevated. The diagnosis relies on low ceruloplasmin, elevated 24-hour urine copper, and liver biopsy. Wilson's disease should be suspected in any young person with unexplained liver disease plus neurological or psychiatric symptoms.
Do I need to worry about copper from drinking water if I have copper pipes?
Modern copper plumbing with properly maintained pipes at normal water pH is unlikely to cause copper toxicity in most adults. However, certain conditions elevate copper leaching: acidic water (pH below 7.0), new or recently disturbed copper plumbing, hot water, and stagnant water that sits in pipes overnight. The EPA action level for copper in drinking water is 1.3 mg/L — levels above this should be addressed with water treatment. People with genetic variants affecting copper metabolism (heterozygous ATP7B carriers, MURR1 variants) may be more susceptible to copper accumulation from borderline exposures. If you have copper pipes and elevated serum copper without another explanation, water copper testing is reasonable.